A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers
Clinical trial NCT02514603 · COMPLETED
Trial details
- NCT number
- NCT02514603
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-04-10
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.